Transcranial magnetic stimulation —
New brain imaging 
  tool
R. J. Ilmoniemi1,2,3
1BioMag 
  Laboratory, Engineering Centre, Helsinki University Central Hospital, P.O. Box 
  340, FIN-00029 HUS, Finland;
2Helsinki Brain Research Center, Helsinki, Finland; 
  3Nexstim Ltd., Elimäenkatu 22 B, FIN-00510 Helsinki, Finland
Abstract: 
  Recent advances in targeting 
  TMS on the basis of 3D MRI images and in combining it with EEG, PET, and fMRI 
  are transforming TMS into a new brain imaging modality. With MRI-based targeting 
  of the stimuli and the ability to measure cortical responses evoked by TMS, 
  one can perform precisely controlled studies on cortical reactivity and connectivity. 
  The new techniques will find applications in cognitive, neurological and psychiatric 
  studies and in therapy.
INTRODUCTION
The brain can be stimulated non-invasively by magnetic 
  field pulses that induce a flow of current in the tissue. This technique, called 
  transcranial magnetic stimulation (TMS), has grown dramatically in popularity 
  since its initial demonstration by Barker et al. in 1985 [1]. 
Initially, most TMS experiments were limited to 
  the stimulation of the motor cortex, because the only effects of the stimulation 
  that could be reliably observed were those reflected in muscular activity. In 
  the past few years, however, it has been demonstrated that one can observe the 
  cortical effects of TMS also directly, e.g., by means of electroencephalography 
  (EEG), positron emission tomography (PET), or functional magnetic resonance 
  imaging (fMRI). 
These developments, together with the possibility 
  to target the stimuli on the basis of 3D MRI, are transforming TMS to a completely 
  new brain mapping modality, which is based on observing brain activity after 
  neurons have been triggered into action in a controlled fashion. 
With TMS, one can 1) measure cortical excitability, 
  2) study the integrity, efficacy, and timing of area-to-area connections, 3) 
  find cortical areas that are important for specific tasks, or 4) treat patients.
The field strength of up to several tesla 
  required in TMS is produced by a strong current in a coil placed over the scalp. 
  The effect in the brain is due to the induced electric current and the consequent 
  depolarization of cell membranes.
The field strengths in TMS are lower than 
  or equal to the field in a typical modern MRI scanner; there is no reason to 
  believe that the direct effect of the magnetic field of a brief pulse would 
  be any more harmful than a static one, which itself appears to pose no danger. 
  Power dissipation due to the TMS-induced electrical currents is also low: the 
  total dissipated power in the brain during 20-Hz repetitive TMS (rTMS) is less 
  than 1 mW, i.e., several orders of magnitude less than the brain’s 
  metabolic power. After over a decade of intense scrutiny, TMS seems to be a 
  rather safe technique [2].
The focality of stimulation depends on the 
  type of coil and on its distance from the head, small coils pressed against 
  the scalp generally producing the most confined stimulation. In early magnetic 
  stimulators, only circular coils were used; better focus can be obtained with 
  the figure-of-eight coil [3]. In the future, we may see arrays of coils, 
  which allow further improved focusing as well as electronic targeting [4,5].
In traditional TMS studies, the coil is placed 
  over the head by using external landmarks or by trial and error until the desired 
  response (e.g., thumb twitch) is generated. In contrast, one can now 
  use navigated TMS, where the coil is positioned on the basis of MRI so that 
  one can define in advance which anatomical feature of the brain is stimulated.
Navigated TMS allows precise definition of the 
  induced electric field strength instead of choosing a percentage of the maximum 
  stimulator output or percentage of the motor threshold. The improved control 
  of stimulus parameters will improve reliability and safety.
TMS combined with multichannel EEG allows one to 
  monitor the spreading of neuronal activation after stimulation [6]. The main 
  advantage of concurrent TMS and EEG is the possibility to study cortical excitability 
  and functional connectivity on a millisecond scale [7].
Paus et al. [8] combined 
  TMS and PET, introducing a new technique that permits the mapping of neural 
  connections in the living human brain. While stimulating a selected cortical 
  area, they simultaneously measured changes in cerebral blood flow. They found 
  significant correlations between cerebral blood flow and the number of TMS pulse 
  trains, demonstrating functional connectivity from the left frontal eye field 
  to visual areas in the superior parietal and medial parieto-occipital cortex.
The use of TMS within an MRI equipment is not straightforward 
  because of the magnetic forces between the two systems and because the TMS coil 
  may distort the MRI images. Nevertheless, it has been shown that TMS-evoked 
  brain activation can be measured by using fMRI [9, 10].
RESULTS
A powerful TMS paradigm was introduced by Amassian 
  et al. [11]: a subject’s performance in a character identification task 
  was impaired when single magnetic pulses were administered between 60 and 140 
  ms after the onset of the visual stimulus; a temporary functional lesion had 
  been created. This technique has been subsequently used in a variety of experiments. 
  For example, Pascual-Leone et al. [12] showed that by applying rTMS to 
  language areas in the dominant hemisphere, speech production can be arrested.
Ziemann et al. [13] 
  studied effects of epileptic drugs on motor cortex excitability using TMS. Kähkönen 
  et al. [14] used TMS with high-resolution EEG to see how ethanol 
  affects TMS-evoked cortical activity. Stimulating the motor cortex in the left 
  hemisphere, they observed alcohol-induced changes not only in the stimulated 
  area, but also in the frontal cortex, including the contralateral hemisphere. 
  It thus appeared that ethanol had changed the functional connectivity between 
  motor and prefrontal cortices.
TMS is used increasingly for depression therapy. 
  George et al. [15] treated medication-resistant depressed patients by 
  applying rTMS to the left dorsolateral prefrontal cortex, where neuronal activity 
  appears to be lowered in depression. Several other authors [16] have subsequently 
  reported positive results on depressed patients, giving hope that rTMS may replace 
  the inconvenient electroconvulsive therapy (ECT) at least in some cases of drug-resistant 
  depression.
rTMS has also been an experimental treatment for 
  patients with obsessive-compulsive disorders [17], post-traumatic stress [18], 
  schizophrenia and Parkinson's disease [19]. However, the physiological mechanisms 
  and the conclusive demonstration of the efficacy of rTMS in therapy still requires 
  extensive clinical trials.
DISCUSSION 
In its 16 years of existence, TMS has evolved into 
  a valuable technique for both clinicians and basic researchers. It is a unique 
  and powerful tool providing a means to examine cortical excitability and connectivity 
  in normal and abnormal human brain in vivo. On the other hand, rTMS has 
  shown promise as an alternative treatment in several psychiatric disorders, 
  in particular in depression. In cognitive neuroscience, the excellent temporal 
  resolution of TMS is invaluable in determining brain–behaviour relations with, 
  e.g., temporary lesion studies. Advances in precise, navigated targeting 
  of TMS, improved techniques for the recording of TMS-evoked activity, integration 
  with MRI and other imaging techniques, and new experimental paradigms and clinical 
  applications promise a bright future for TMS. One can say that a new brain imaging 
  tool has emerged.
Acknowledgments: Supported by the Academy 
  of Finland and Helsinki University Central Hospital Research Funds.
REFERENCES
[1] A.T. Barker, R. Jalinous, I.L. Freeston, “Non-invasive 
  magnetic stimulation of human motor cortex,” Lancet, vol. 1, pp. 1106–1107, 
  1985.
[2] E.M. Wassermann, “Risk and safety of repetitive 
  transcranial magnetic stimulation: report and suggested guidelines from the 
  International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, 
  June 5–7, 1996,” Electroenceph. Clin. Neurophysiol., vol. 108, pp. 1–16, 
  1998.
[3] S. Ueno, T. Tashiro, and K. Harada, “Localized 
  stimulation of neural tissues in the brain by means of a paired configuration 
  of time-varying magnetic fields,” J. Appl. Phys., vol. 64, 5862–5864, 
  1988.
[4] R. Ilmoniemi and F. Grandori, Finnish Patent 
  No. 100458, 1997.
[5] J. Ruohonen and R.J. Ilmoniemi, “Focusing and 
  targeting of magnetic brain stimulation using multiple coils,” Med. Biol. 
  Eng. Comput., vol. 36, pp. 297–301, 1998.
[6] R.J. Ilmoniemi, J. Virtanen, J. Ruohonen et 
  al., “Neuronal responses to magnetic stimulation reveal cortical reactivity 
  and connectivity,” NeuroReport, vol. 8, 3537–3540, 1997.
[7] S. Komssi, H.J. Aronen, J. Huttunen, et al., 
  “Ipsi- and contralateral EEG reactions to transcranial magnetic stimulation,” 
  Clin. Neurophysiol., vol. 113, 175–184, 2002. 
[8] T. Paus, R. Jech, C.J. Thompson et al., “Transcranial 
  magnetic stimulation during positron emission tomography: A new method for studying 
  connectivity of the human cerebral cortex,” J. Neurosci., vol. 17, 3178–3184, 
  1997.
[9] O. Josephs, B.S. Athwal, C. Mackinnon et al., 
  “Transcranial magnetic stimulation with simultaneous undistorted functional 
  magnetic resonance imaging,” NeuroImage, vol. 9, S124, 1999.
[10] D.E. Bohning, A. Shastri, E.M. Wassermann et 
  al., “BOLD-fMRI response to single-pulse transcranial magnetic stimulation (TMS),” 
  J. Magn. Reson. Imaging, vol. 11, 569–574, 2000.
[11] V.E. Amassian, R.Q. Cracco, P.J. Maccabee et 
  al., “Suppression of visual perception by magnetic coil stimulation of human 
  occipital cortex,” Electroenceph. Clin. Neurophysiol., vol. 74, 458–462, 
  1989.
[12] A. Pascual-Leone, J.R. Gates, and A. Dhuna, 
  “Induction of speech arrest and counting errors with rapid-rate transcranial 
  magnetic stimulation,” Neurology, vol. 41, 697–702, 1991.
[13] U. Ziemann, S. Lönnecker, B.J. Steinhoff et 
  al., “Effects of antiepileptic drugs on motor cortex excitability in humans: 
  a transcranial magnetic stimulation study,” Ann. Neurol., vol. 40, 367–378, 
  1996.
[14] S. Kähkönen, M. Kesäniemi, V.V. Nikouline et 
  al., “Ethanol modulates cortical activity: direct evidence with combined TMS 
  and EEG,” NeuroImage, vol. 12, 1649–1652, 2001.
[15] M.S. George, E.M. Wassermann, W.A. Williams 
  et al., “Daily repetitive transcranial magnetic stimulation (rTMS) improves 
  mood in depression,” NeuroReport, vol. 6, 1853–1856, 1995.
[16] A. Pascual-Leone, B. Rubio, F. Pallardo, et 
  al., “Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal 
  cortex in drug-resistant depression,” Lancet, vol. 348, 233–237, 1996.
[17] B.D. Greenberg, M.S. George, J.D. Martin et 
  al., “Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive 
  disorder: a preliminary study,” Am. J. Psychiatry, vol. 154, 867–869, 
  1997.
[18] U.D. McCann, T.A. Kimbrell, C.M. Morgan et 
  al., “Repetitive transcranial magnetic stimulation for posttraumatic stress 
  disorder,” Arch. Gen. Psychiatry, vol. 55, 276–279, 1998.
[19] A. Pascual-Leone and M.D. Catala, “Lasting 
  beneficial effect of rapid rate transcranial magnetic stimulation on slowness 
  in Parkinson's disease,” Neurology, vol. 45, 550, 1995.